- Report
- December 2024
- 91 Pages
Global
From €3495EUR$3,950USD£3,022GBP
- Report
- August 2025
- 148 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- June 2025
- 150 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- June 2025
- 150 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- June 2025
- 145 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- May 2025
- 140 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- April 2025
- 142 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- April 2025
- 139 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- March 2025
- 138 Pages
Global
From €2654EUR$2,999USD£2,295GBP
- Report
- September 2025
- 280 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 377 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 485 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 471 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 469 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 172 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 274 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 476 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 278 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 483 Pages
Global
From €5176EUR$5,850USD£4,476GBP
- Report
- September 2025
- 280 Pages
Global
From €5176EUR$5,850USD£4,476GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more